APO Research
Talk to an analyst

APO RESEARCH · REPORT

Epigenetics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Epigenetics Market Outlook and Growth Opportunities 2026

20 December 2025205 pages

Choose your research edition.

Industry ResearchEpigenetics Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Epigenetics Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Epigenetics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Epigenetics Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Epigenetics Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Epigenetics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Epigenetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Epigenetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Epigenetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Epigenetics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Epigenetics market include Abcam, Active Motif, Agilent, Bio-Rad, CellCentric Ltd., Diagenode, EpiGentek, Epizyme Inc. and Illumina, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Epigenetics market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Epigenetics and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Epigenetics revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Epigenetics market.

Epigenetics Segment by Company

Abcam

Active Motif

Agilent

Bio-Rad

CellCentric Ltd.

Diagenode

EpiGentek

Epizyme Inc.

Illumina

New England Biolabs

Perkinelmer

Qiagen

ValiRx plc

Zymo Research

Merck & Co.

Thermo Fisher Scientific

Epigenetics Segment by Type

Enzymes

Reagents

Kits & Assays

Instruments and Consumables

Epigenetics Segment by Application

Contract Research Organizations (CROs)

Biotechnology Companies

Academic & Research Institutes

Pharmaceutical Companies

Others

Epigenetics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Epigenetics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Epigenetics key companies, revenue, market share, and recent developments.

3. To split the Epigenetics breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Epigenetics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Epigenetics significant trends, drivers, influence factors in global and regions.

6. To analyze Epigenetics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epigenetics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Epigenetics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epigenetics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Epigenetics industry.

Chapter 3: Detailed analysis of Epigenetics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Epigenetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Epigenetics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Epigenetics Industry Trends Table 2. Epigenetics Industry Drivers Table 3. Epigenetics Industry Opportunities and Challenges Table 4. Epigenetics Industry Restraints Table 5. Global Epigenetics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Epigenetics Revenue Share by Company (2021-2026) Table 7. Global Epigenetics Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Epigenetics Key Company Manufacturing Base & Headquarters Table 9. Global Epigenetics Company, Product Type & Application Table 10. Global Epigenetics Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Epigenetics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Enzymes Table 15. Significant Companies of Reagents Table 16. Significant Companies of Kits & Assays Table 17. Significant Companies of Instruments and Consumables Table 18. Global Epigenetics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Epigenetics Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Epigenetics Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Epigenetics Sales Value Share by Type (2021-2026) Table 22. Global Epigenetics Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Contract Research Organizations (CROs) Table 24. Significant Companies of Biotechnology Companies Table 25. Significant Companies of Academic & Research Institutes Table 26. Significant Companies of Pharmaceutical Companies Table 27. Significant Companies of Others Table 28. Global Epigenetics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Epigenetics Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Epigenetics Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Epigenetics Sales Value Share by Application (2021-2026) Table 32. Global Epigenetics Sales Value Share by Application (2027-2032) Table 33. Global Epigenetics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Epigenetics Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Epigenetics Sales Value Share by Region (2021-2026) Table 36. Global Epigenetics Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Epigenetics Sales Value Share by Region (2027-2032) Table 38. Global Epigenetics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Epigenetics Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Epigenetics Sales Value Market Share by Country (2021-2026) Table 41. Global Epigenetics Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Epigenetics Sales Value Market Share by Country (2027-2032) Table 43. Abcam Company Information Table 44. Abcam Business Overview Table 45. Abcam Epigenetics Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Abcam Epigenetics Product Portfolio Table 47. Abcam Recent Development Table 48. Active Motif Company Information Table 49. Active Motif Business Overview Table 50. Active Motif Epigenetics Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Active Motif Epigenetics Product Portfolio Table 52. Active Motif Recent Development Table 53. Agilent Company Information Table 54. Agilent Business Overview Table 55. Agilent Epigenetics Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Agilent Epigenetics Product Portfolio Table 57. Agilent Recent Development Table 58. Bio-Rad Company Information Table 59. Bio-Rad Business Overview Table 60. Bio-Rad Epigenetics Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Bio-Rad Epigenetics Product Portfolio Table 62. Bio-Rad Recent Development Table 63. CellCentric Ltd. Company Information Table 64. CellCentric Ltd. Business Overview Table 65. CellCentric Ltd. Epigenetics Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. CellCentric Ltd. Epigenetics Product Portfolio Table 67. CellCentric Ltd. Recent Development Table 68. Diagenode Company Information Table 69. Diagenode Business Overview Table 70. Diagenode Epigenetics Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Diagenode Epigenetics Product Portfolio Table 72. Diagenode Recent Development Table 73. EpiGentek Company Information Table 74. EpiGentek Business Overview Table 75. EpiGentek Epigenetics Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. EpiGentek Epigenetics Product Portfolio Table 77. EpiGentek Recent Development Table 78. Epizyme Inc. Company Information Table 79. Epizyme Inc. Business Overview Table 80. Epizyme Inc. Epigenetics Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Epizyme Inc. Epigenetics Product Portfolio Table 82. Epizyme Inc. Recent Development Table 83. Illumina Company Information Table 84. Illumina Business Overview Table 85. Illumina Epigenetics Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Illumina Epigenetics Product Portfolio Table 87. Illumina Recent Development Table 88. New England Biolabs Company Information Table 89. New England Biolabs Business Overview Table 90. New England Biolabs Epigenetics Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. New England Biolabs Epigenetics Product Portfolio Table 92. New England Biolabs Recent Development Table 93. Perkinelmer Company Information Table 94. Perkinelmer Business Overview Table 95. Perkinelmer Epigenetics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Perkinelmer Epigenetics Product Portfolio Table 97. Perkinelmer Recent Development Table 98. Qiagen Company Information Table 99. Qiagen Business Overview Table 100. Qiagen Epigenetics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Qiagen Epigenetics Product Portfolio Table 102. Qiagen Recent Development Table 103. ValiRx plc Company Information Table 104. ValiRx plc Business Overview Table 105. ValiRx plc Epigenetics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. ValiRx plc Epigenetics Product Portfolio Table 107. ValiRx plc Recent Development Table 108. Zymo Research Company Information Table 109. Zymo Research Business Overview Table 110. Zymo Research Epigenetics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Zymo Research Epigenetics Product Portfolio Table 112. Zymo Research Recent Development Table 113. Merck & Co. Company Information Table 114. Merck & Co. Business Overview Table 115. Merck & Co. Epigenetics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Merck & Co. Epigenetics Product Portfolio Table 117. Merck & Co. Recent Development Table 118. Thermo Fisher Scientific Company Information Table 119. Thermo Fisher Scientific Business Overview Table 120. Thermo Fisher Scientific Epigenetics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Thermo Fisher Scientific Epigenetics Product Portfolio Table 122. Thermo Fisher Scientific Recent Development Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Epigenetics Product Image Figure 2. Global Epigenetics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Epigenetics Market Size (2021-2032) & (US$ Million) Figure 4. Global Epigenetics Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Enzymes Image Figure 8. Reagents Image Figure 9. Kits & Assays Image Figure 10. Instruments and Consumables Image Figure 11. Global Epigenetics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Epigenetics Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Epigenetics Sales Value Share by Type (2021-2032) Figure 14. Contract Research Organizations (CROs) Image Figure 15. Biotechnology Companies Image Figure 16. Academic & Research Institutes Image Figure 17. Pharmaceutical Companies Image Figure 18. Others Image Figure 19. Global Epigenetics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Epigenetics Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Epigenetics Sales Value Share by Application (2021-2032) Figure 22. Global Epigenetics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Epigenetics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Epigenetics Sales Value (2021-2032) & (US$ Million) Figure 25. North America Epigenetics Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Epigenetics Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Epigenetics Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Epigenetics Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Epigenetics Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Epigenetics Sales Value (2021-2032) & (US$ Million) Figure 31. South America Epigenetics Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Epigenetics Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Epigenetics Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Epigenetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Epigenetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Epigenetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Enzymes
  • Reagents
  • Kits & Assays
  • Instruments and Consumables
Applications
  • Contract Research Organizations (CROs)
  • Biotechnology Companies
  • Academic & Research Institutes
  • Pharmaceutical Companies
  • Others
Companies covered
  • Abcam
  • Active Motif
  • Agilent
  • Bio-Rad
  • CellCentric Ltd.
  • Diagenode
  • EpiGentek
  • Epizyme Inc.
  • Illumina
  • New England Biolabs
  • Perkinelmer
  • Qiagen
  • ValiRx plc
  • Zymo Research
  • Merck & Co.
  • Thermo Fisher Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Epigenetics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Epigenetics Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Epigenetics Market Dynamics
  1. 2.1 Epigenetics Industry Trends
  2. 2.2 Epigenetics Industry Drivers
  3. 2.3 Epigenetics Industry Opportunities and Challenges
  4. 2.4 Epigenetics Industry Restraints
3 Epigenetics Market by Company
  1. 3.1 Global Epigenetics Company Revenue Ranking in 2025
  2. 3.2 Global Epigenetics Revenue by Company (2021-2026)
  3. 3.3 Global Epigenetics Company Ranking (2024-2026)
  4. 3.4 Global Epigenetics Company Manufacturing Base and Headquarters
  5. 3.5 Global Epigenetics Company Product Type and Application
  6. 3.6 Global Epigenetics Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Epigenetics Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Epigenetics Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Epigenetics Market by Type
  1. 4.1 Epigenetics Type Introduction
  2. 4.1.1 Enzymes
  3. 4.1.2 Reagents
  4. 4.1.3 Kits & Assays
  5. 4.1.4 Instruments and Consumables
  6. 4.2 Global Epigenetics Sales Value by Type
  7. 4.2.1 Global Epigenetics Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Epigenetics Sales Value by Type (2021-2032)
  9. 4.2.3 Global Epigenetics Sales Value Share by Type (2021-2032)
5 Epigenetics Market by Application
  1. 5.1 Epigenetics Application Introduction
  2. 5.1.1 Contract Research Organizations (CROs)
  3. 5.1.2 Biotechnology Companies
  4. 5.1.3 Academic & Research Institutes
  5. 5.1.4 Pharmaceutical Companies
  6. 5.1.5 Others
  7. 5.2 Global Epigenetics Sales Value by Application
  8. 5.2.1 Global Epigenetics Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Epigenetics Sales Value by Application (2021-2032)
  10. 5.2.3 Global Epigenetics Sales Value Share by Application (2021-2032)
6 Epigenetics Regional Value Analysis
  1. 6.1 Global Epigenetics Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Epigenetics Sales Value by Region (2021-2032)
  3. 6.2.1 Global Epigenetics Sales Value by Region: 2021-2026
  4. 6.2.2 Global Epigenetics Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Epigenetics Sales Value (2021-2032)
  7. 6.3.2 North America Epigenetics Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Epigenetics Sales Value (2021-2032)
  10. 6.4.2 Europe Epigenetics Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Epigenetics Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Epigenetics Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Epigenetics Sales Value (2021-2032)
  16. 6.6.2 South America Epigenetics Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Epigenetics Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Epigenetics Sales Value Share by Country, 2025 VS 2032
7 Epigenetics Country-level Value Analysis
  1. 7.1 Global Epigenetics Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Epigenetics Sales Value by Country (2021-2032)
  3. 7.2.1 Global Epigenetics Sales Value by Country (2021-2026)
  4. 7.2.2 Global Epigenetics Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Epigenetics Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Epigenetics Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Epigenetics Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Epigenetics Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Epigenetics Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Epigenetics Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Epigenetics Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Epigenetics Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Epigenetics Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Epigenetics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Epigenetics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Epigenetics Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Epigenetics Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Epigenetics Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Epigenetics Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Epigenetics Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Epigenetics Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Epigenetics Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Epigenetics Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Epigenetics Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Epigenetics Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Epigenetics Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Epigenetics Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Epigenetics Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Epigenetics Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Epigenetics Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Epigenetics Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Epigenetics Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Epigenetics Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Epigenetics Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Epigenetics Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Epigenetics Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Epigenetics Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Epigenetics Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Epigenetics Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Epigenetics Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Epigenetics Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Epigenetics Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Epigenetics Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Epigenetics Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Epigenetics Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Epigenetics Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Epigenetics Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Epigenetics Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Epigenetics Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Epigenetics Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Epigenetics Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Epigenetics Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Epigenetics Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Epigenetics Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Epigenetics Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Epigenetics Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Epigenetics Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Epigenetics Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Epigenetics Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Epigenetics Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Epigenetics Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Epigenetics Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Epigenetics Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Epigenetics Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Epigenetics Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Epigenetics Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Epigenetics Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Epigenetics Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Epigenetics Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Epigenetics Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Epigenetics Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Epigenetics Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Epigenetics Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Epigenetics Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Epigenetics Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Epigenetics Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Epigenetics Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Epigenetics Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Epigenetics Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Epigenetics Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Epigenetics Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Epigenetics Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Epigenetics Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Epigenetics Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Epigenetics Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Epigenetics Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Epigenetics Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Epigenetics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abcam
  2. 8.1.1 Abcam Company Information
  3. 8.1.2 Abcam Business Overview
  4. 8.1.3 Abcam Epigenetics Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abcam Epigenetics Product Portfolio
  6. 8.1.5 Abcam Recent Developments
  7. 8.2 Active Motif
  8. 8.2.1 Active Motif Company Information
  9. 8.2.2 Active Motif Business Overview
  10. 8.2.3 Active Motif Epigenetics Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Active Motif Epigenetics Product Portfolio
  12. 8.2.5 Active Motif Recent Developments
  13. 8.3 Agilent
  14. 8.3.1 Agilent Company Information
  15. 8.3.2 Agilent Business Overview
  16. 8.3.3 Agilent Epigenetics Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Agilent Epigenetics Product Portfolio
  18. 8.3.5 Agilent Recent Developments
  19. 8.4 Bio-Rad
  20. 8.4.1 Bio-Rad Company Information
  21. 8.4.2 Bio-Rad Business Overview
  22. 8.4.3 Bio-Rad Epigenetics Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bio-Rad Epigenetics Product Portfolio
  24. 8.4.5 Bio-Rad Recent Developments
  25. 8.5 CellCentric Ltd.
  26. 8.5.1 CellCentric Ltd. Company Information
  27. 8.5.2 CellCentric Ltd. Business Overview
  28. 8.5.3 CellCentric Ltd. Epigenetics Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CellCentric Ltd. Epigenetics Product Portfolio
  30. 8.5.5 CellCentric Ltd. Recent Developments
  31. 8.6 Diagenode
  32. 8.6.1 Diagenode Company Information
  33. 8.6.2 Diagenode Business Overview
  34. 8.6.3 Diagenode Epigenetics Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Diagenode Epigenetics Product Portfolio
  36. 8.6.5 Diagenode Recent Developments
  37. 8.7 EpiGentek
  38. 8.7.1 EpiGentek Company Information
  39. 8.7.2 EpiGentek Business Overview
  40. 8.7.3 EpiGentek Epigenetics Revenue and Gross Margin (2021-2026)
  41. 8.7.4 EpiGentek Epigenetics Product Portfolio
  42. 8.7.5 EpiGentek Recent Developments
  43. 8.8 Epizyme Inc.
  44. 8.8.1 Epizyme Inc. Company Information
  45. 8.8.2 Epizyme Inc. Business Overview
  46. 8.8.3 Epizyme Inc. Epigenetics Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Epizyme Inc. Epigenetics Product Portfolio
  48. 8.8.5 Epizyme Inc. Recent Developments
  49. 8.9 Illumina
  50. 8.9.1 Illumina Company Information
  51. 8.9.2 Illumina Business Overview
  52. 8.9.3 Illumina Epigenetics Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Illumina Epigenetics Product Portfolio
  54. 8.9.5 Illumina Recent Developments
  55. 8.10 New England Biolabs
  56. 8.10.1 New England Biolabs Company Information
  57. 8.10.2 New England Biolabs Business Overview
  58. 8.10.3 New England Biolabs Epigenetics Revenue and Gross Margin (2021-2026)
  59. 8.10.4 New England Biolabs Epigenetics Product Portfolio
  60. 8.10.5 New England Biolabs Recent Developments
  61. 8.11 Perkinelmer
  62. 8.11.1 Perkinelmer Company Information
  63. 8.11.2 Perkinelmer Business Overview
  64. 8.11.3 Perkinelmer Epigenetics Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Perkinelmer Epigenetics Product Portfolio
  66. 8.11.5 Perkinelmer Recent Developments
  67. 8.12 Qiagen
  68. 8.12.1 Qiagen Company Information
  69. 8.12.2 Qiagen Business Overview
  70. 8.12.3 Qiagen Epigenetics Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Qiagen Epigenetics Product Portfolio
  72. 8.12.5 Qiagen Recent Developments
  73. 8.13 ValiRx plc
  74. 8.13.1 ValiRx plc Company Information
  75. 8.13.2 ValiRx plc Business Overview
  76. 8.13.3 ValiRx plc Epigenetics Revenue and Gross Margin (2021-2026)
  77. 8.13.4 ValiRx plc Epigenetics Product Portfolio
  78. 8.13.5 ValiRx plc Recent Developments
  79. 8.14 Zymo Research
  80. 8.14.1 Zymo Research Company Information
  81. 8.14.2 Zymo Research Business Overview
  82. 8.14.3 Zymo Research Epigenetics Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Zymo Research Epigenetics Product Portfolio
  84. 8.14.5 Zymo Research Recent Developments
  85. 8.15 Merck & Co.
  86. 8.15.1 Merck & Co. Company Information
  87. 8.15.2 Merck & Co. Business Overview
  88. 8.15.3 Merck & Co. Epigenetics Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Merck & Co. Epigenetics Product Portfolio
  90. 8.15.5 Merck & Co. Recent Developments
  91. 8.16 Thermo Fisher Scientific
  92. 8.16.1 Thermo Fisher Scientific Company Information
  93. 8.16.2 Thermo Fisher Scientific Business Overview
  94. 8.16.3 Thermo Fisher Scientific Epigenetics Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Thermo Fisher Scientific Epigenetics Product Portfolio
  96. 8.16.5 Thermo Fisher Scientific Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst